Rising demand for personalized interiors, eco-friendly materials, and online retail boosts global wall decor market at 4.5% ...

The United States has taken possession of a Boeing 747 jet gifted by the Qatari government, according to multiple news ...

Pharmaceutical manufacturing encompasses all processes involved in the manufacturing and production of biological and medical products, botanical drugs, and herbs, as well as other pharmaceutical ...

F or an interior designer who appreciates historic touches, there’s nothing better than taking on a home project still dripping with the original charm. Maggie Clarke wasn’t s ...

Aurobindo Pharma Limited reported a fire incident at its subsidiary Lyfius Pharma Private Limited’s Penicillin-G manufacturing facility in Kakinada SEZ, Andhra Pradesh. The incident occurred at ...

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...

A Cambridge-based pharmaceutical company is laying off close to a hundred employees. Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last ...

Ahmedabad: Gujarat has further cemented its position as India's pharmaceutical powerhouse with the state's Food and Drug Control Administration (FDCA) approving 183 new allopathic drug ...

Chief Executives don’t usually brag about paying high tax rates. But with pharma tariffs looming, being a tax sucker is suddenly a badge of safety in the industry. That isn’t because Wall ...

But that could soon change. For months, President Trump has been promising to impose higher tariffs on pharmaceuticals as part of his plan to reorder the global trading system and bring key ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. The head of Zealand Pharma has called its $5.3bn partnership with Roche to commercialise an obesity drug ...

LONDON, April 25 (Reuters) - A 25% U.S. tariff on pharmaceutical imports would increase U.S. drug costs by nearly $51 billion annually, boosting U.S. prices by as much as 12.9% if passed on ...